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Abstract
Background: There are no objective and accurate rating tools for permanent impairment of traumatized ankles.
The purpose of this study is to assess the role of 18F-Sodium fluoride (18F-NaF) positron emission tomography-
computed tomography (PET/CT) bone scans in evaluating patients with limited ankle range of motion (ROM) after
trauma.
Methods: 18F-NaF PET/CT was performed in 121 patients (75 men, 46 women; mean age: 45.8) who had ROM <
70% of normal after trauma affecting ankles. Metabolic target volume (MTV), the sum of voxels with standardized
uptake value (SUV) > 2.5 was automatically obtained from the 3D volume that included the ankle joint. The
maximum & mean SUV (SUVmax & SUVmean), and the total lesion activity (TLA) were measured.
Results: The median period from injury to performing 18F-NaF PET/CT was 290 days. The causes of injury were as
follows: fracture (N = 95), Achilles tendon rupture (N = 12), and ligament injury (N = 12). Hot uptake in the ankle was
seen in 113 of 121 patients. The fracture group had higher SUVmax, SUVmean, and TLA values than the non-
fracture group. More limited ROM correlated with higher hot-uptake parameters (SUVmax, SUVmean, TLA). In
subgroup analysis, the same correlations were present in the fracture, but not in the non-fracture group.
Conclusions: 18F-NaF PET/CT can provide considerable information in impairment evaluations of limited ankle
ROM, particularly in fracture around the ankle. Thus, 18F-NaF bone PET/CT may provide an additional option as an
objective imaging tool in disability assessment after ankle injury.
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Background
Limitation of range of motion (ROM) in the ankle is com-
mon after ankle trauma, even after the time has passed for
maximum medical improvement (MMI). Ankle stiffness
causes difficulties in walking and restrictions in the activ-
ities of daily living, which is worse when it is accompanied
by pain. The objective and accurate rating of permanent
impairment is very important in workers’ compensation
programs or automobile insurance, to determine an
appropriate level of financial compensation [1, 2]. How-
ever, the impairment of ROM in the ankle joint is difficult
to evaluate because it is based on direct observations, such
as the patients’ own activities, which can be subjective and
are easily influenced by pain or by their motivations to im-
prove, rather than on objective measurement [3]. Radio-
logic studies performed immediately after injury are
helpful to provide information about the severity of the
trauma; however, after achieving MMI, it is impossible to
find a correlation between the functional impairment of
the ankle joint (pain or limitation of ROM) and the latest
objective radiologic assessments (simple plain radiog-
raphy, computerized tomography [CT], or magnetic res-
onance imaging).
Impairment of the ankle joint, such as contracture or
limitation of ROM, can occur after traumatic injury; its
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pathomechanism may be explained by the concept of
posttraumatic osteoarthritis (PTA) [4]. Ankle PTA after
intra-articular injury could be related to the initial ar-
ticular cartilage and subchondral bone damage, inad-
equate reduction of joint surfaces, or complications in
the healing process [4–6]. Extra-articular injuries not in-
volving joint structures could also cause end-stage ankle
PTA by chronic instability or the long-term effects of
posttraumatic malalignment [4, 7]. Furthermore, fibrosis
of the soft tissue can play a role in post-traumatic joint
contractures [8]. Posttraumatic Immobilization induces
limitation of ROM by disuse osteoporosis and reversible
bone loss with increased osteoclastic bone resorption in
the mechanically unloaded bone [9]. However, to date,
no biomarker has been available to represent ROM of
the joint after injury.
Bone scanning using 18F-sodium fluoride (18F-NaF)
was performed by Blau et al. in 1962, [10] but this was
rapidly replaced by technetium-99 m (99mTc)-labeled
bone imaging agents after the introduction of gamma
cameras equipped with a thallium-doped sodium iodide
(NaI [Tl]) crystal. However, as positron emission tomog-
raphy (PET) cameras came into use, interest in 18F-NaF
bone scanning has renewed [11]. The uptake mechanism
of 18F-NaF and 99mTc-labeled diphosphonate is essen-
tially the same, involving chemisorption, and the amount
of bone accumulation depends on blood flow and the
exposed bone surface [12]. However, negligible plasma
protein binding, and the rapid blood and renal clearance
of NaF permits earlier image acquisition after tracer ad-
ministration. Therefore, 18F-NaF bone scanning has sev-
eral advantages, such as enabling high spatial resolution,
attenuating correction, allowing 3D tomographic im-
aging, as well as hybrid PET/CT imaging [11, 13]. Simi-
lar to 99mTc agents, 18F-NaF has been mainly used for
evaluation of bone metastasis; however, these high reso-
lution tomographic images, with their corresponding CT
images, are also very useful for evaluation of benign joint
disease, such as enthesopathy, degenerative joint disease,
and osteophytosis [14].
Impairment of ankle ROM after trauma has commonly
been evaluated by physical examination by a doctor or
therapist, which is subjective, rather than objective
quantitative evaluation of images. In this study, the role
of 18F-NaF bone PET/CT in the evaluation of impair-
ment in trauma patients with limited ankle ROM was
assessed.
Methods
Patients
Between September 2013 and March 2017, 121 patients
(75 men and 46 women, mean age: 45.8 years; range:
17–75 years) were recruited into the study (Table 1);
these patients had limited ankle ROM at least 6 months
after traumatic injury affecting their ankles. The etiology
of injury varied: 1) fracture with intra-articular involve-
ment of the tibiotalar joint, 2) fracture without
intra-articular involvement, 3) ligament injury, 4) Achil-
les tendon rupture, and 5) others. These individuals
attended the outpatients’ clinic of a university hospital
for an evaluation of the impairment of their ankles. For
the impairment rating, the ROM of the ankle joint was
measured according to “AMA Guides to the Evaluation
of Permanent Impairment” [15]. Images of the ankles
were obtained by plain radiography and 18F-NaF PET/
CT. The study was approved by the institutional review
board of our institute, and written informed consent was
obtained from all study participants.
18F-NaF bone PET/CT imaging
18F-NaF bone PET/CT imaging was conducted in accord-
ance with SNM practice guidelines for Sodium F-18 Fluor-
ide PET/CT bone scan 1.0 [16]. Patient fasting was not
required, and 5.18 MBq/kg (0.14 mCi/kg) of 18F-NaF was
injected. Regional PET with non-contrast-enhanced CT
for attenuation correction was performed consecutively,
60 min after the injection of 18F-NaF, by means of a dedi-
cated PET/CT system (Biograph mCT; Siemens Health-
care, Munich, Germany). The parameters for CT were
120 kVp, effective mAs controlled by Care Dose 4D soft-
ware, 0.5-s gantry rotation, and 0.6-mm collimation. The
kernel for CT reconstruction was the B60f sharp-type.
18F-NaF PET images so acquired were reconstructed
using True X and time of flight (TOF), ultra-high defin-
ition (HD)-PET.
Imaging analysis
18F-NaF PET/CT images of 121 patients with limited
ROM of the ankle were reviewed using the dedicated soft-
ware for PET/CT workstation (Syngo VE32B, Siemens
AG). Metabolic target volume (MTV), the sum of voxels
with a standardized uptake value (SUV) > 2.5 was auto-
matically obtained from the 3D volume that included the
Table 1 Demographic data of 121 patients
Sex
Male 75
Female 46
Mean Age (range) 45.8 (17–75)
Etiology of Injury
Fracture with intra-articular involvement of the
tibiotalar joint
54
Fracture without intra-articular involvement 41
Ligament injury 12
Achilles tendon rupture 12
Others 3
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ankle joint. MTV represented the active extent of
trauma-related joint disease, similar to the metabolic
tumor volume that is widely used in the oncology field.
Within these MTVs, maximum and mean SUV (SUVmax
and SUVmean) were measured. The total lesion activity
(TLA) was also determined; this concept was adopted
from total lesion glycolysis (TLG), and was the product of
the SUVmean and MTV. These parameters express add-
itional information about disease activity in terms of dis-
ease extent, represented by MTV [17].
Statistical analysis
Data were analyzed using SPSS 23.0 statistical software
(SPSS Inc., Chicago, IL). An independent t-test was used
to compare hot-uptake parameters of 18F-NaF PET/CT
between the fracture group and non-fracture group. The
relationship between ankle ROM and hot-uptake param-
eters of 18F-NaF PET/CT was analyzed using Pearson’s
correlation coefficient. P < .05 was considered to indicate
statistically significant differences.
Results
The median period from injury to performing 18F-NaF
PET/CT was 290 days (range: 180–2396). The causes of
injury were as follows: fracture (N = 95; tibia, and/or fibu-
lar, and/or calcaneus), Achilles tendon rupture (N = 12),
complex regional pain syndrome (N = 2), ligament injury
(N = 12, anterior talofibular ligament, and/or calcaneofibu-
lar ligament, and/or deltoid ligament). Quantitative
analysis of 18F-NaF PET/CT revealed that 113 of 121 pa-
tients had hot uptake (SUVmax > 2.5) in the ROI (region
of interest) of the ankle, whereas the remaining 8 did not.
All 8 patients who did not show hot uptake were in the
non-fracture group. Representative cases are presented in
Figs. 1 and 2.
The SUVmax (13.31 ± 9.42 vs. 5.33 ± 3.24, p < .01), SUV-
mean (5.92 ± 4.94 vs. 3.07 ± 1.68, p < .05), and TLA
(268.03 ± 349.76 vs. 73.05 ± 106.20, p < .05, Table 2) values
were higher in the fracture than in the non-fracture group.
The fracture group also showed a tendency for higher
values in MTV than non-fracture group without statistical
significance (p = .068). A more limited ROM of the ankle
was correlated with higher hot-uptake parameters of
18F-NaF PET/CT: SUVmax (ρ = − 0.335, p < .01), SUV-
mean (ρ = − 0.343, p < .01), MTV (ρ = − 0.252, < 0.05), and
TLA (ρ = − 0.305, p < .01, Table 3). In a subgroup analysis,
the fracture group revealed similar results: SUVmax (ρ =
− 0.336, p < .01), SUVmean (ρ = − 0.354, p < .01), and TLA
(ρ = − 0.292, p < .05), whereas these tendencies were not
observed in the non-fracture group (Table 3).
Discussion
According to our retrospective study of 18F-NaF PET/
CT findings, most patients with limited ROM after ankle
trauma (113/121 = 93.4%) showed hot uptake around the
ankle joint. However, several cases (8/26 = 30.8%) in the
non-fracture group did not reveal hot uptake on PET/
CT, and even if some hot uptake was observed, there
Fig. 1 Radiological and 18F-Sodium fluoride (18F-NaF) positron emission tomography-computed tomography (PET/CT) images of a 37-year-old
male patient who had a fracture of the left medial and posterior malleolus of the tibia. a-d Initial images of plain radiographs and computed
tomography (CT); a ankle anterior-posterior view, b ankle lateral view, c ankle CT coronal view, d ankle CT lateral view. Note that the fracture
involved the talocrural (tibiotalar) joint. e, f Plain radiographs after internal fixation with a metal pin. g-i Plain radiographs performed at
17 months after injury presents pin removal status and osteoporotic changes around the ankle joint, but does not provide any information about
the degree of ankylosis in the ankle. j-l) 18F-NaF PET/CT shows hot uptake around the talocrural joint near the initial fracture area
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was no statistical significant correlation between the de-
gree of hot uptake and the limitation of ankle ROM
(Table 3). In contrast, 100% patients in the fracture
group (N = 95) showed hot uptake around the ankle
joint, and the quantitative parameters (SUVmax and
SUVmean, but not MTV) were statistically significantly
correlated with the limitation of ankle ROM (Table 3).
Therefore, it can be assumed that the “intensity” of hot
uptake was more relevant than the “spread” of hot up-
take. These results suggest that 18F-NaF bone PET/CT
can be an objective imaging tool for evaluating ankle
joint disability in patients with ankle fracture.
In our study, higher hot uptake parameters of
18F-NaF PET/CT were correlated with more limited
ROM of the ankle joint. As 18F-NaF is a bone imaging
agent, the higher uptake of this agent in patients with
greater immobility and soft tissue rigidity requires some
explanation. Tatsuya et al. reported arthroscopic
mobilization of the wrist by removing a septum that was
assumed to have developed after trauma [8]. They re-
ported that this septum could not be detected by plain
radiographs, magnetic resonance image, or CT. More-
over, they reported that arthroscopic surgery could not
restore the full ROM, and that immature chondrocytes
were observed around the fibers. Furthermore, the joint
contracture could be produced by altered length-tension
relationships and neuromuscular mechanisms after frac-
tures [18]. During the period of ankle fixation, some
Fig. 2 Radiologic and 18F-sodium fluoride (18F-NaF) positron emission tomography-computed tomography (PET/CT) images of a 53-year-old
male patient who had a right calcaneus fracture and underwent operation with plate-screw fixation. a-d Initial images of plain radiographs and
computed tomography (CT); a calcaneal anterior-posterior view, b calcaneal CT axial view, c ankle lateral view, d calcaneal CT lateral view. Note
that the fracture did not involve the talocrural (tibiotalar) joint. e, f Plain radiographs performed at 9 months after injury presents plate-screw
fixation, but does not give any information about talocrural joint pathology and the degree of ankylosis in the ankle. g-i 18F-NaF PET/CT shows
hot uptake around the talocrural joint away from the initial fracture and plate-screw fixation area
Table 2 Comparison of hot uptake parameters of 18F-NaF PET/
CT between the fracture group and the non-fracture group
Fracture (N = 95) Non-fracture (N = 26) p-value
SUVmax 13.31 ± 9.42 5.33 ± 3.24 0.001
SUVmean 5.92 ± 4.94 3.07 ± 1.68 0.017
MTV 52.40 ± 67.09 22.86 ± 29.72 0.068
TLA 268.03 ± 349.76 73.05 ± 106.20 0.019
Values represent the mean ± standard deviation
18F-NaF PET/CT, 18-Fluorine sodium fluoride bone positron emission
tomography-computed tomography; MTV metabolic target volume, SUVmax
maximum standardized uptake value, SUVmean mean standardized uptake
value, TLA total lesion activity
Table 3 Correlation coefficient between ankle ROM and hot
uptake parameters of 18F-NaF PET/CT
Total (N = 121) Fracture (N = 95) Non-fracture (N = 26)
SUVmax - 0.335** - 0.336* - 0.102
SUVmean - 0.343** - 0.354** - 0.059
MTV - 0.252* - 0.223 - 0.317
TLA - 0.305** - 0.292* - 0.265
Values represent Pearson’s correlation coefficient. * P < 0.05, ** P < 0.01
18F-NaF PET/CT, 18-Fluorine sodium fluoride bone positron emission
tomography-computed tomography; MTV metabolic target volume, ROM
range of motion, SUVmax maximum standardized uptake value, SUVmean
mean standardized uptake value, TLA total lesion activity
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changes in neuromuscular conditions occur due to
immobilization to protect against overstretching of the
fragile musculature around the ankle joint [18]. In light
of these findings about soft tissue contracture after joint
trauma, the higher bone uptake of 18F-NaF in the pa-
tients with greater ROM limitation may be attributable
to greater immobility caused by tighter contracture.
Greater immobility is expected to cause more disuse
osteoporosis. Disuse osteoporosis involves reversible
bone loss, associated with increased osteoclastic bone re-
sorption in the mechanically unloaded bone [9]. The
bones affected by disuse osteoporosis are associated with
eventually greater turnover of bones and show a high ra-
diopharmaceutical uptake reflecting osteoblastic activity
[19]. Greater joint contracture is therefore expected to
cause more disuse osteoporosis, and consequently more
osteoblastic activities which are represented as radio-
pharmaceutical uptake in 18F-NaF PET/CT [14, 20]. In-
creased osteoblastic activities may cause hypertrophic
sclerosis which leads pseudoarthroses and chronic
disability.
Fluorodeoxyglucose (FDG) PET/CT indicates the tis-
sue glucose metabolic rate, and thus, when it is per-
formed for trauma-related arthritis, it mainly reflects the
inflammatory process in the soft tissue in the joint [21].
However, FDG uptake is not sensitive for detection of
bone formation or periosteal bone reaction. Although
conventional bone scintigraphy is known to have high
sensitivity for detection of bone reaction, its resolution
is not high and exact localization of hot-uptake lesions is
not possible [22]. Recently, SPECT/CT using 99mTc-la-
beled agents is available in some hospitals, but has rela-
tively low image resolution and a long scan-time.
Therefore, we evaluated the use of 18F-NaF bone PET/
CT to validate bone reaction in the complicated bony
structure of the ankle, because of its high resolution and
sensitivity, as well as its ability to allow exact lesion
localization.
Trauma involving the ankle joint can occur anywhere,
such as work-related injury, a road traffic accident, or
slipping in a public area. Although patients typically
have significant improvement after appropriate initial
treatment, they often still have residual physical impair-
ment several years after the injury [23–25]. Because
these cases can be related to medicolegal or various
compensation issues, objective evaluation of permanent
impairment is very important. Although ROM appears
to be a suitable method for evaluating impairment of the
ankle joint [26, 27], it may be subject to variation, be-
cause patients may complain of pain during motion at
different times during the examination, and may be de-
liberately uncooperative and inconsistent. With such in-
consistency, ROM assessment cannot be used as a valid
parameter in impairment evaluations [26]. Under these
conditions, 18F-NaF bone PET/CT findings could be
used as useful information for increasing the reliability
of impairment evaluations. The results of our study sug-
gest that hot uptake of 18F-NaF bone PET/CT reflects
greater impairment, even if the ankle ROM assessment
is somewhat inconsistent. However, it should not be
concluded that less hot uptake of 18F-NaF during bone
PET/CT indicates deception by the patients during im-
pairment evaluation.
Our study had some limitations. Because this study
was a pilot study, no control group was employed, which
may be considered a limitation. A no-ROM limitation
group, even after ankle injury, would facilitate under-
standing of the role of 18F-NaF bone PET/CT in per-
manent impairment evaluation. However, it is very
difficult to recruit patients who have no physical impair-
ment several months after ankle injury, as they would
usually not visit the hospital regularly and there would
be no reason to undergo expensive imaging examina-
tions, such as PET/CT. The numbers between the frac-
ture group and non-fracture group were much differed
in this study (95 vs. 26). The reason for this is that the
study was not a prospective study, and it is the patients
in fracture group are more likely to have a disability be-
cause the impact of accident may be greater than
non-fracture group. Moreover, we did not consider the
effect of other factors that may affect hot uptake of
18F-NaF bone PET/CT, such as age, sex, and amount of
physical activity of the patients. Further evaluation was
not performed for several conditions or factors that
could affect bone metabolism, such as diabetes mellitus,
osteoporosis, and the use of steroids. Further studies are
necessary to accumulate more 18F-NaF bone PET/CT
data in the context of ankle injury in order to establish a
cut-off value for adjudication of permanent impairment.
Conclusions
18F-NaF PET/CT can provide considerable information
in impairment evaluations of limited ankle ROM, par-
ticularly in patients with fracture around the ankle joint.
Therefore, it can be assumed that the “intensity” of hot
uptake was more relevant than the “spread” of hot
uptake.
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